Membrane proteins that protect against complement lysis

The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNA

Yamamoto, T., Davis, C. G., Brown, M. S., Schneider, W. J., Casey, M. L., Goldstein, J. L., & Russell, D. W. (1984) · Cell · doi:10.1016/0092-8674(84)90188-0 · Cited by 1,382

Structural and Functional Roles of Glycosyl-Phosphatidylinositol in Membranes

Low, M. G., & Saltiel, A. R. (1988) · Science · doi:10.1126/science.3276003 · Cited by 952

Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte

Fearon, D. (1980) · The Journal of Experimental Medicine · doi:10.1084/jem.152.1.20 · Cited by 644

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.

Davies, A., Simmons, D. L., Hale, G., Harrison, R. A., Tighe, H., Lachmann, P. J., & Waldmann, H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.3.637 · Cited by 633

Membrane Cofactor Protein (MCP or CD46): Newest Member of the Regulators of Complement Activation Gene Cluster

Liszewski, M. K., Post, T. W., & Atkinson, J. P. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.002243 · Cited by 589

Molecular cloning of cDNA encoding human interleukin-2 receptor

Nikaido, T., Shimizu, A., Ishida, N., Sabe, H., Teshigawara, K., Maeda, M., Uchiyama, T., Yodoi, J., & Honjo, T. (1984) · Nature · doi:10.1038/311631a0 · Cited by 565

Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.

Medof, M. E., Kinoshita, T., & Nussenzweig, V (1984) · The Journal of experimental medicine · doi:10.1084/jem.160.5.1558 · Cited by 561

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers.

Meri, S., Morgan, B. P., Davies, A., Daniels, R. H., Olavesen, M. G., Waldmann, H., & Lachmann, P. J. (1990) · PubMed Central · Cited by 533

Decay-Accelerating Factor: Biochemistry, Molecular Biology, And Function

Lublin, D. (1989) · Annual Review of Immunology · doi:10.1146/annurev.immunol.7.1.35 · Cited by 496

Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane

Fearon, D. T. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5867 · Cited by 440

The Regulators of Complement Activation (RCA) Gene Cluster

Hourcade, D., Holers, V. M., & Atkinson, J. P. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60697-5 · Cited by 439

Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Nicholson-Weller, A., March, J. P., Rosenfeld, S. I., & Austen, K. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.16.5066 · Cited by 428

The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.

Rollins, S. A., & Sims, P. J. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.9.3478 · Cited by 405

Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Holguin, M. H., Fredrick, L. R., Bernshaw, N. J., Wilcox, L. A., & Parker, C. J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114172 · Cited by 403

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.

Kinoshita, T., Medof, M. E., Silber, R., & Nussenzweig, V (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.1.75 · Cited by 400

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

Seya, T., Turner, J. R., & Atkinson, J. P. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.4.837 · Cited by 398

The Role of Complement and Its Receptor in the Elimination of Immune Complexes

Epstein, F. H., Schifferli, J. A., Ng, Y. C., & Peters, D. K. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608213150805 · Cited by 396

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

Morgan, B. P. (1989) · Biochemical Journal · doi:10.1042/bj2640001 · Cited by 380

Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein.

Davitz, M. A., Low, M. G., & Nussenzweig, V (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.5.1150 · Cited by 353

Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins

Caras, I. W., Davitz, M. A., Rhee, L., Weddell, G., Martin, D. W., & Nussenzweig, V. (1987) · Nature · doi:10.1038/325545a0 · Cited by 351

Inherited Complete Deficiency of 20-Kilodalton Homologous Restriction Factor (CD59) as a Cause of Paroxysmal Nocturnal Hemoglobinuria

Yamashina, M., Ueda, E., Kinoshita, T., Takami, T., Ojima, A., Ono, H., Tanaka, H., Kondo, N., Orii, T., Okada, N., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199010253231707 · Cited by 351

Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.

Iida, K., Mornaghi, R., & Nussenzweig, V (1982) · The Journal of experimental medicine · doi:10.1084/jem.155.5.1427 · Cited by 339

Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.

Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5430 · Cited by 317

Complement Ligand-Receptor Interactions that Mediate Biological Responses

Fearon, D. T., & Wong, W. W. (1983) · Annual Review of Immunology · doi:10.1146/annurev.iy.01.040183.001331 · Cited by 290

Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid

Medof, M. E., Walter, E. I., Roberts, W. L., Haas, R., & Rosenberry, T. L. (1986) · Biochemistry · doi:10.1021/bi00370a003 · Cited by 286

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.

Klickstein, L. B., Bartow, T. J., Miletic, V, Rabson, L. D., Smith, J. A., & Fearon, D. T. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1699 · Cited by 271

INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTOR: POTENTIAL FOR PREVENTION OF XENOGRAFT HYPERACUTE REJECTION

DALMASSO, A. P., VERCELLOTTI, G. M., PLATT, J. L., & BACH, F. H. (1991) · Transplantation · doi:10.1097/00007890-199109000-00029 · Cited by 264

Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins.

Klickstein, L. B., Wong, W. W., Smith, J. A., Weis, J. H., Wilson, J. G., & Fearon, D. T. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.4.1095 · Cited by 261

Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement.

Medof, M. E., Lublin, D. M., Holers, V. M., Ayers, D. J., Getty, R. R., Leykam, J. F., Atkinson, J. P., & Tykocinski, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2007 · Cited by 254

Human follicular dendritic cells express CR1, CR2, and CR3 complement receptor antigens.

Reynes, M., Aubert, J. P., Cohen, J. H. M., Audouin, J., Tricottet, V, Diebold, J., & Kazatchkine, M. D. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2687 · Cited by 237

Signal for Attachment of a Phospholipid Membrane Anchor in Decay Accelerating Factor

Caras, I. W., Weddell, G. N., Davitz, M. A., Nussenzweig, V., & Martin, D. W. (1987) · Science · doi:10.1126/science.2446389 · Cited by 210

Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9

Rollins, S. A., Zhao, J., Ninomiya, H., & Sims, P. J. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.7.2345 · Cited by 206

The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.

Fujita, T., Inoue, T., Ogawa, K., Iida, K., & Tamura, N. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.5.1221 · Cited by 204

Physiologic relevance of the membrane attack complex inhibitory protein CD59 in human seminal plasma: CD59 is present on extracellular organelles (prostasomes), binds cell membranes, and inhibits complement-mediated lysis.

Rooney, I. A., Atkinson, J. P., Krul, E. S., Schonfeld, G., Polakoski, K., Saffitz, J. E., & Morgan, B. P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1409 · Cited by 199

Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues.

Meri, S., Waldmann, H., & Lachmann, P. J. (1991) · PubMed · Cited by 196

Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria

Rosse, W. (1990) · Blood · doi:10.1182/blood.v75.8.1595.1595 · Cited by 190

Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies.

Malek, T. R., Ortega, G., Chan, C., Kroczek, R. A., & Shevach, E. M. (1986) · The Journal of Experimental Medicine · doi:10.1084/jem.164.3.709 · Cited by 185

Membrane cofactor protein of the complement system: alternative splicing of serine/threonine/proline-rich exons and cytoplasmic tails produces multiple isoforms that correlate with protein phenotype.

Post, T. W., Liszewski, M. K., Adams, E. M., et al. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.1.93 · Cited by 178

Structure, Organization, And Regulation Of The Complement Genes

Campbell, R. D., Law, S. K. A., Reid, K. B. M., & Sim, R. B. (1988) · Annual Review of Immunology · doi:10.1146/annurev.iy.06.040188.001113 · Cited by 178

Overlapping but Nonidentical Binding Sites on CD2 for CD58 and a Second Ligand CD59

Hahn, W. C., Menu, E., Bothwell, A. L. M., Sims, P. J., & Bierer, B. E. (1992) · Science · doi:10.1126/science.1377404 · Cited by 167

Functional properties of membrane cofactor protein of complement

Seya, T., & Atkinson, J. (1989) · Biochemical Journal · doi:10.1042/bj2640581 · Cited by 162

Human genes for three complement components that regulate the activation of C3 are tightly linked.

de Córdoba, S. R., Lublin, D. M., Rubinstein, P. G., & Atkinson, J. P. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.5.1189 · Cited by 159

Complement regulatory proteins at the feto‐maternal interface during human placental development: distribution of CD59 by comparison with membrane cofactor protein(CD46) and decay accelerating factor (CD55)

Holmes, C. H., Simpson, K. L., Okada, H., et al. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220635 · Cited by 158

Deficiency of the Complement Regulatory Protein, Decay-Accelerating Factor, on Membranes of Granulocytes, Monocytes, and Platelets in Paroxysmal Nocturnal Hemoglobinuria

Nicholson-Weller, A., Spicer, D. B., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198504253121704 · Cited by 152

CD59 functions as a signal-transducing molecule for human T cell activation

Korty, P. E., Brando, C., & Shevach, E. M. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.12.4092 · Cited by 151

Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.

Walter, E. I., Roberts, W. L., Rosenberry, T. L., Ratnoff, W. D., & Medof, M. E. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.3.1030 · Cited by 144

Polymorphism of human erythrocyte C3b/C4b receptor.

Dykman, T. R., Cole, J. L., Iida, K., & Atkinson, J. P. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1698 · Cited by 143

Contribution of the repeating domains of membrane cofactor protein (CD46) of the complement system to ligand binding and cofactor activity

Adams, E. M., Brown, M. C., Nunge, M., Krych, M., & Atkinson, J. P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.9.3005 · Cited by 137

Genetic regulation of a structural polymorphism of human C3b receptor.

Wong, W. W., Wilson, J. G., & Fearon, D. T. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111018 · Cited by 132

Characterization of a broadly expressed human leucocyte surface antigen MEM-43 anchored in membrane through phosphatidylinositol

Štefanová, I., Hilgert, I., Kristofová, H., Brown, R., Low, M. G., & Hořejší, V. (1989) · Molecular Immunology · doi:10.1016/0161-5890(89)90097-7 · Cited by 131

Effects of the Membrane Attack Complex of Complement on Nucleated Cells

Morgan, B. P. (1992) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-77014-2_8 · Cited by 130

Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy.

Holmes, C., Simpson, K. L., Wainwright, S., Tate, C., Houlihan, J., Sawyer, I. H., Rogers, I., Spring, F., Anstee, D., & Tanner, M. (1990) · Journal of Immunology · doi:10.4049/jimmunol.144.8.3099 · Cited by 130

Homologous species restriction in lysis of erythrocytes by terminal complement proteins.

Hänsch, G. M., Hammer, C. H., Vanguri, P., & Shin, M. L. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5118 · Cited by 127

Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.

Lublin, D. M., & Coyne, K. E. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.1.35 · Cited by 125

Sites within the complement C3b/C4b receptor important for the specificity of ligand binding.

Krych, M., Hourcade, D. E., & Atkinson, J. P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4353 · Cited by 122

20 KDa homologous restriction factor of complement resembles T cell activating protein

Okada, H., Nagami, Y., Takahashi, K., Okada, N., Hideshima, T., Takizawa, H., & Kondo, J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)90852-8 · Cited by 114

Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.

Hänsch, G. M., Schönermark, S., & Roelcke, D. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113065 · Cited by 112

Structure of the human CR1 gene. Molecular basis of the structural and quantitative polymorphisms and identification of a new CR1-like allele.

Wong, W. W., Cahill, J. M., Rosen, M. D., Kennedy, C. A., Bonaccio, E. T., Morris, M. J., Wilson, J. G., Klickstein, L. B., & Fearon, D. T. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.847 · Cited by 108

Regulatory control of complement on blood platelets

Sims, P. J., Rollins, S. A., & Wiedmer, T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47291-8 · Cited by 106

Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

McGeer, P. L., Walker, D. G., Akiyama, H., Kawamata, T., Guan, A. L., Parker, C. J., Okada, N., & McGeer, E. G. (1991) · Brain Research · doi:10.1016/0006-8993(91)90071-3 · Cited by 105

The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Schifferli, J. A., Ng, Y. C., Paccaud, J. P., & Walport, M. J. (1989) · PubMed Central · Cited by 102

The glycosyl phosphatidylinositol anchor is critical for Ly-6A/E-mediated T cell activation.

Su, B., Waneck, G. L., Flavell, R. A., & Bothwell, A. L. M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.112.3.377 · Cited by 96

Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.

Shin, M. L., Hänsch, G. M., Hu, V. W., & Nicholson-Weller, A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.5.1777 · Cited by 92

Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction.

Väkevä, A., Laurila, P., & Meri, S. (1992) · PubMed · Cited by 90

Structure of the gene for human complement protein decay accelerating factor.

Post, T. W., Arce, M. A., Liszewski, M. K., Thompson, E., Atkinson, J. P., & Lublin, D. M. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.2.740 · Cited by 88

Endogenous association of decay-accelerating factor (DAF) with C4b and C3b on cell membranes.

Kinoshita, T., Medof, M. E., & Nussenzweig, V. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3390 · Cited by 78

Identification of an alternative polyadenylation site in the human C3b/C4b receptor (complement receptor type 1) transcriptional unit and prediction of a secreted form of complement receptor type 1.

Hourcade, D. E., Miesner, D. R., Atkinson, J. P., & Holers, V. M. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.168.4.1255 · Cited by 77

Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation

Purcell, D. F. J., Russell, S. M., Deacon, N. J., et al. (1991) · Immunogenetics · doi:10.1007/bf00216692 · Cited by 75

CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation

Deckert, M., Kubar, J., & Bernard, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.3.672 · Cited by 73

Increased expression of complement decay-accelerating factor during activation of human neutrophils.

Berger, M., & Medof, M. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112786 · Cited by 71

Regulatory control of the terminal complement proteins at the surface of human endothelial cells: neutralization of a C5b-9 inhibitor by antibody to CD59

Hamilton, K., Ji, Z., Rollins, S. A., Stewart, B., & Sims, P. (1990) · Blood · doi:10.1182/blood.v76.12.2572.2572 · Cited by 69

Contribution of the N-linked carbohydrate of erythrocyte antigen CD59 to its complement-inhibitory activity.

Ninomiya, H., Stewart, B. H., Rollins, S. A., Zhao, J., Bothwell, A. L. M., & Sims, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42459-3 · Cited by 68

Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor

Holguin, M. H., Martin, C. B., Bernshaw, N. J., et al. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.2.498 · Cited by 65

Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids

WATTS, M. J., Dankert, J. R., & Morgan, B. P. (1990) · Biochemical Journal · doi:10.1042/bj2650471 · Cited by 65

Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus

Moldenhauer, F., David, J., Fielder, A. H. L., Lachmann, P. J., & Walport, M. J. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300901 · Cited by 63

Fusion of sequence elements from non-anchored proteins to generate a fully functional signal for glycophosphatidylinositol membrane anchor attachment.

Moran, P., & Caras, I. W. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.6.1595 · Cited by 62

Identification of a third component of complement-binding glycoprotein of human platelets.

Yu, G., Holers, V. M., Seya, T., Ballard, L., & Atkinson, J. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112601 · Cited by 56

CD59 expressed by human endothelial cells functions as a protective molecule against complement‐mediated lysis

Brooimans, R. A., van der Ark, A. A., Tomita, M., van Es, L. A., & Daha, M. R. (1992) · European Journal of Immunology · doi:10.1002/eji.1830220324 · Cited by 56

Isolation and characterization of the complement-inhibiting protein CD59 antigen from platelet membranes

Morgan, B. P. (1992) · Biochemical Journal · doi:10.1042/bj2820409 · Cited by 50

Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro.

Horta, M. F., Ramalho-Pinto, F. J., & Fatima, M. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.6.1399 · Cited by 50

Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cells.

Tandon, N., Morgan, B. P., & Weetman, A. P. (1992) · PubMed Central · Cited by 46

Duplication and divergence of the amino-terminal coding region of the complement receptor 1 (CR1) gene. An example of concerted (horizontal) evolution within a gene.

Hourcade, D. E., Miesner, D. R., Bee, C., Zeldes, W., & Atkinson, J. P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40145-2 · Cited by 36

Expression of CR1 (CD35) mRNA in podocytes from adult and fetal human kidneys

Appay, M., Kazatchkine, M. D., Lévi‐Strauss, M., Hinglais, N., & Bariety, J. (1990) · Kidney International · doi:10.1038/ki.1990.198 · Cited by 34

Isolation and Expression of the Full-Length cDNA Encoding CD59 Antigen of Human Lymphocytes

Sawada, R., Ohashi, K., Anaguchi, H., Okazaki, H., Hattori, M., Minato, N., & Naruto, M. (1990) · DNA and Cell Biology · doi:10.1089/dna.1990.9.213 · Cited by 28

Erythrocytes of patients with paroxysmal nocturnal haemoglobinuria acquire resistance to complement attack by purified 20-kD homologous restriction factor

Okada, N., HARADA, R., & OKADA, H. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb06449.x · Cited by 26

Self-protection of cytotoxic lymphocytes: a soluble form of homologous restriction factor in cytoplasmic granules.

Zalman, L. S., Brothers, M. A., & Müller‐Eberhard, H. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4827 · Cited by 26

Structural and Functional Correlation of the Human Complement Receptor Type 1

Wong, W. W. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12875150 · Cited by 26

Transplantation of Organs Between Species

White, D. J. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000236157 · Cited by 25

The Homologous Species Restriction of the Complement Attack: Structure and Function of the C8 Binding Protein

Hänsch, G. M. (1988) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-73911-8_9 · Cited by 20

Self‐nonself discrimination by the complement system

Meri, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12284 · Cited by 87